Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
Titel:
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
Auteur:
Masi, G. Salvatore, L. Boni, L. Loupakis, F. Cremolini, C. Fornaro, L. Schirripa, M. Cupini, S. Barbara, C. Safina, V. Granetto, C. Fea, E. Antonuzzo, L. Boni, C. Allegrini, G. Chiara, S. Amoroso, D. Bonetti, A. Falcone, A.